Pharmacokinetics
Kinetics
refers to movement. Pharmacokinetics deals with a drug’s actions as it moves
through the body. Therefore, pharmaco-kinetics discusses how a drug is:
·
absorbed (taken into the
body)
·
distributed (moved into
various tissues)
·
metabolized (changed
into a form that can be excreted)
·
excreted (removed from
the body).
This
branch of pharmacology is also concerned with a drug’s onset of action, peak
concentration level, and duration of action.
Drug absorption covers a drug’s progress from the
time it’s admin-istered, through its passage to the tissues, until it reaches
systemic circulation.
On a cellular level, drugs are absorbed by several
means—pri-marily through active or passive transport.
Passive transport requires no cellular energy becausediffusion
allows the drug to move from an area of high-er concentration to one of lower
concentration. Passive transport occurs when small molecules diffuse across
membranes and stops when drug concentration on both sides of the membrane is
equal.
Active transport requires cellular energy to move the drug
froman area of lower concentration to one of higher concentration. Ac-tive
transport is used to absorb electrolytes, such as sodium and potassium, as well
as some drugs such as levodopa.
Pinocytosis is a unique form of active transport that
occurs whena cell engulfs a drug particle. Pinocytosis is commonly employed to
transport fat-soluble vitamins (vitamins A, D, E, and K).
If only a few cells separate the active drug from
the systemic cir-culation, absorption will occur rapidly and the drug will
quickly reach therapeutic levels in the body. Typically, absorption occurs
within seconds or minutes when a drug is administered sublin-gually, I.V., or
by inhalation.
Absorption occurs at a slower rate when drugs are
administered by the oral, I.M., or subQ routes because the complex membrane
systems of GI mucosal layers, muscle, and skin delay drug pas-sage.
At the slowest absorption rates, drugs can take
several hours or days to reach peak concentration levels. A slow rate usually
oc-curs with rectally administered or sustained-release drugs.
Other factors can affect how quickly a drug is
absorbed. For ex-ample, most absorption of oral drugs occurs in the small
intestine. If a patient has had large sections of the small intestine
surgically removed, drug absorption decreases because of the reduced sur-face
area and the reduced time that the drug is in the intestine.
Drugs absorbed by the small intestine are
transported to the liver before being circulated to the rest of the body. The
liver may me-tabolize much of the drug before it enters the circulation. This
mechanism is referred to as the first-pass
effect. Liver metabolism may inactivate the drug; if so, the first-pass
effect lowers the amount of active drug released into the systemic circulation.
Therefore, higher drug dosages must be administered to achieve the desired
effect.
Increased blood flow to an absorption site improves
drug absorp-tion, whereas reduced blood flow decreases absorption. More rapid
absorption leads to a quicker onset of drug action.
For example, the muscle area selected for I.M.
administration can make a difference in the drug absorption rate. Blood flows
faster through the deltoid muscle (in the upper arm) than through the gluteal
muscle (in the buttocks). The gluteal muscle, however, can accommodate a larger
volume of drug than the deltoid mus-cle.
Pain and stress can decrease the amount of drug
absorbed. This may be due to a change in blood flow, reduced movement through
the GI tract, or gastric retention triggered by the autonomic ner-vous system
response to pain.
High-fat meals and solid foods slow the rate
at which contents leave the stomach and enter the intestines, delaying
intestinal ab-sorption of a drug.
Drug formulation (such as tablets, capsules,
liquids, sustained-release formulas, inactive ingredients, and coatings)
affects the drug absorption rate and the time needed to reach peak blood
concentration levels.
Combining one drug with another drug, or with food,
can cause in-teractions that increase or decrease drug absorption, depending on
the substances involved.
Drug distribution is the process by which the drug
is delivered from the systemic circulation to body tissues and fluids.
Distribu-tion of an absorbed drug within the body depends on several fac-tors:
·
blood flow
·
solubility
·
protein binding.
After a drug has reached the bloodstream, its
distribution in the body depends on blood flow. The drug is quickly distributed
to or-gans with a large supply of blood. These organs include the:
·
heart
·
liver
·
kidneys.
Distribution to other internal organs, skin, fat,
and muscle is slower.
The ability of a drug to cross a cell membrane
depends on whether the drug is water or lipid (fat) soluble. Lipid-soluble
drugs easily cross through cell membranes; water-soluble drugs can’t.
Lipid-soluble drugs can also cross the blood-brain
barrier and enter the brain.
As a drug travels through the body, it comes in
contact with pro-teins such as the plasma protein albumin. The drug can remain
free or bind to the protein. The portion of a drug that’s bound to a protein is
inactive and can’t exert a therapeutic effect. Only the free, or unbound,
portion remains active.
A drug is said to be highly protein-bound if more
than 80% of the drug is bound to protein.
Drug metabolism, or biotransformation, is the
process by which the body changes a drug from its dosage form to a more
water-soluble form that can then be excret-ed. Drugs can be metabolized in
several ways:
·
Most drugs are metabolized into inactive metabolites (products of
metabolism), which are then excreted.
·
Other drugs are converted to active metabolites, which are capable of
exerting their own pharmacologic action. Active metabolites may undergo further
metabolism or may be excreted from the body unchanged.
·
Some drugs can be administered as inactive drugs, called pro-drugs, which don’t become active
until they’re metabolized.
The majority of drugs are metabolized by enzymes in
the liver; however, metabolism can also occur in the plasma, kidneys, and
membranes of the intestines. In contrast, some drugs inhibit or compete for
enzyme metabolism, which can cause the accumula-tion of drugs when they’re
given together. This accumulation in-creases the potential for an adverse
reaction or drug toxicity.
Certain diseases can reduce metabolism. These
include liver dis-eases such as cirrhosis as well as heart failure, which
reduces cir-culation to the liver.
Genetics allows some people to metabolize drugs
rapidly and oth-ers to metabolize them more slowly.
Environment, too, can alter drug metabolism. For
example, ciga-rette smoke may affect the rate of metabolism of some drugs; a
stressful situation or event, such as prolonged illness, surgery, or injury,
can also change how a person metabolizes drugs.
Developmental changes can also affect drug
metabolism. For in-stance, infants have immature livers that reduce the rate of
metab-olism, and elderly patients experience a decline in liver size, blood
flow, and enzyme production that also slows metabolism.
Drug excretion refers to the elimination of
drugs from the body. Most drugs are excreted by the kidneys and leave the body
through urine. Drugs can also be excreted through the lungs, ex-ocrine (sweat,
salivary, or mammary) glands, skin, and intestinal tract.
The half-life of a drug is the time it takes for
one-half of the drug to be eliminated by the body. Factors that affect a drug’s
half-life include its rate of absorption, metabolism, and excretion. Know-ing
how long a drug remains in the body helps determine how fre-quently it should
be administered.
A drug that’s given only once is eliminated from
the body al-most completely after four or five half-lives. A drug that’s
adminis-tered at regular intervals, however, reaches a steady concentra-tion
(or steady state) after about four or five half-lives. Steady state occurs when
the rate of drug administration equals the rate of drug excretion.
In addition to absorption, distribution,
metabolism, and excretion, three other factors play important roles in a drug’s
pharmacoki-netics:
·
onset of action
·
peak concentration
·
duration of action.
The onset of action refers to the time interval
from when the drug is administered to when its therapeutic effect actually
begins. Rate of onset varies depending on the route of administration and other
pharmacokinetic properties.
As the body absorbs more drug, blood concentration
levels rise. The peak concentration level is reached when the absorption
rateequals the elimination rate. However, the time of peak concentra-tion isn’t
always the time of peak response.
The duration of action is the length of time the
drug produces its therapeutic effect.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.